Podcast
MSL Talk: Tom Caravela, Sarah Snyder
MSL Training: The Path of Continued Learning and Development
Summary
In this episode, Michael Parisi and Marissa Polly from GuideMark Health join to explore the evolving training needs of Medical Science Liaisons (MSLs). They discuss the essential scientific and clinical skills required, alongside strategies for reengaging field medical teams post-COVID. The conversation highlights the importance of soft skills and empathy in MSL success, and offers insights into enhancing operational training and territory management. Michael and Marissa also address the challenges new MSLs face during career transitions, inviting listener input. The episode concludes with closing remarks and a note of appreciation, with GuideMark Health as the sponsor.
Check out my latest podcast with Michael Parisi and Marissa Poli of Guidemark Health as we cover MSL Training: The Path of Continued Learning and Development.
We discuss:
Core Competency-Scientific and Clinical Training
Soft Skills and Empathy Training
Operational Skills in a Virtual World
Career On Ramp Training
MSL training, medical science liaison skills, soft skills in healthcare, operational training for MSLs, career transition for MSLs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Sarah Snyder
Podcast
MSL Talk: Tom Caravela, John Caskey
Prepare to LAUNCH: How to Build an MSL Team From Scratch
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary